Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W C Beasley

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Vaccine|November 10, 2009
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virusMelissa C Whiteman, Li Li, Jason A Wicker, et al.
NPJ Vaccines|March 28, 2018
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and developmentHoai J Hallam, Steven Hallam, Sergio E Rodriguez, et al.
Virology|March 31, 2007
Solution structure of the envelope protein domain III of dengue-4 virusDavid E Volk, Yi-Chien Lee, Xin Li, et al.
Virology|February 6, 2009
Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and TrinidadDal Y Kim, Hilda Guzman, Rudy Bueno, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse modelJosé Peña, Jessica A Plante, Alda Celena Carillo, et al.
Virology|May 22, 2003
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United StatesDavid W C Beasley, C Todd Davis, Hilda Guzman, et al.
The Journal of General Virology|July 18, 2008
Genetic variation of St. Louis encephalitis virusFiona J May, Li Li, Shuliu Zhang, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Reduced avian virulence and viremia of West Nile virus isolates from Mexico and TexasAaron C Brault, Stanley A Langevin, Wanichaya N Ramey, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2024
Rapid <i>in vitro</i> activity of telavancin against <i>Bacillus anthracis</i> and <i>in vivo</i> protection against inhalation anthrax infection in the rabbit modelWilliam S Lawrence, Jennifer E Peel, Richard A Slayden, et al.
Pathogens (Basel, Switzerland)|September 25, 2020
Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit ModelWilliam S Lawrence, Jennifer E Peel, Satheesh K Sivasubramani, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Vaccine|November 10, 2009
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virusMelissa C Whiteman, Li Li, Jason A Wicker, et al.
NPJ Vaccines|March 28, 2018
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and developmentHoai J Hallam, Steven Hallam, Sergio E Rodriguez, et al.
Virology|March 31, 2007
Solution structure of the envelope protein domain III of dengue-4 virusDavid E Volk, Yi-Chien Lee, Xin Li, et al.
Virology|February 6, 2009
Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and TrinidadDal Y Kim, Hilda Guzman, Rudy Bueno, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse modelJosé Peña, Jessica A Plante, Alda Celena Carillo, et al.
Virology|May 22, 2003
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United StatesDavid W C Beasley, C Todd Davis, Hilda Guzman, et al.
The Journal of General Virology|July 18, 2008
Genetic variation of St. Louis encephalitis virusFiona J May, Li Li, Shuliu Zhang, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Reduced avian virulence and viremia of West Nile virus isolates from Mexico and TexasAaron C Brault, Stanley A Langevin, Wanichaya N Ramey, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2024
Rapid <i>in vitro</i> activity of telavancin against <i>Bacillus anthracis</i> and <i>in vivo</i> protection against inhalation anthrax infection in the rabbit modelWilliam S Lawrence, Jennifer E Peel, Richard A Slayden, et al.
Pathogens (Basel, Switzerland)|September 25, 2020
Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit ModelWilliam S Lawrence, Jennifer E Peel, Satheesh K Sivasubramani, et al.
Pageof 9